- Previous Close
3.8000 - Open
3.7000 - Bid 3.7200 x --
- Ask 3.7800 x --
- Day's Range
3.6600 - 3.8800 - 52 Week Range
3.5200 - 37.6000 - Volume
74,178 - Avg. Volume
75,703 - Market Cap (intraday)
77.048M - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-2.2900 - Earnings Date Feb 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
14.00
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
www.clinicallaser.seRecent News: CLS-B.ST
View MorePerformance Overview: CLS-B.ST
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLS-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLS-B.ST
View MoreValuation Measures
Market Cap
77.05M
Enterprise Value
61.92M
Trailing P/E
1.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.86
Price/Book (mrq)
1.26
Enterprise Value/Revenue
3.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.36%
Return on Equity (ttm)
-107.80%
Revenue (ttm)
18.63M
Net Income Avi to Common (ttm)
-64.2M
Diluted EPS (ttm)
-2.2900
Balance Sheet and Cash Flow
Total Cash (mrq)
15.58M
Total Debt/Equity (mrq)
2.82%
Levered Free Cash Flow (ttm)
-44.11M